Research and education: federal funding cuts: the National Institutes of Health and postsecondary educational institutions.
If enacted, SJR4 would highlight the extensive financial dependency of California research institutions on NIH funding, noting that California is the largest recipient of NIH funds nationally, receiving over $5 billion annually. The loss of indirect funding is projected to jeopardize hundreds of millions of dollars essential for covering administrative and facility costs associated with research. Additionally, the resolution addresses the broader implications of these federal cuts on job support within the state, directly correlating NIH investments to job creation and public health advancements.
Senate Joint Resolution No. 4 (SJR4) urges the U.S. administration and Congress to reverse funding cuts imposed by the National Institutes of Health (NIH) that significantly impact postsecondary educational institutions. Introduced by Senators Laird, Cabaldon, Limn, and Prez on April 10, 2025, the resolution emphasizes the importance of NIH funding in supporting biomedical research, which benefits public health and the economy in California. The bill draws attention to the detrimental effects of a new limit on indirect funding for research institutions, which has been reduced from nearly 30% to just 15%. This reduction threatens the viability of numerous ongoing studies and programs integral to understanding and combatting diseases such as cancer, diabetes, and conditions prevalent in rural communities.
Concerns surrounding the resolution include the perception that the funding cuts particularly affect marginalized groups and critical areas of public health interest, such as research on LGBTQ+ issues and vaccine hesitancy. The resolution cites previous funding cancellations tied to perceived political motivations, suggesting that such cuts may selectively undermine research that is not aligned with current federal priorities. This has raised alarms among researchers and advocacy groups, prompting legal action against the NIH to halt the implementation of the funding cuts, reflecting a growing tension between legislative support for research and federal administrative policies.